European School of Medicinal Chemistry ESMEC
Urbino, Campus “Collegi del Colle e Tridente”
June 26 – July 1, 2016
The mission of the ESMEC is to provide participants, PhD students and junior researchers from both academia and industry, with the most recent advances in the field of medicinal and organic chemistry, pharmacology, molecular biology and analytical/ structural chemistry. This idea is aimed to reflect the current scenario of medicinal chemistry being a truly transdisciplinary approach, where the advances in knowledge are driven by the medicinal chemist’s ability to translate into new molecular concepts and into novel molecular entities the amount of information created by molecular medicine, pharmacology, molecular biology, systems biology.
For these reasons, the School is directed to participants at a graduated and post-graduated level, in chemistry but also in pharmacology or biology, who are keen to explore the interdisciplinary context of current cutting-edge research in medicinal chemistry.
To achieve these very ambitious goals, the School is organized into thematic sessions, each of them constructed around a series of lectures, followed by practical workshops.
This year the scientific programme includes the following topics:
Drug discovery: perspectives in the war on cancer
- Prof. Giulio Draetta (University of Texas – USA)
- Dr. Paul W. Manley (Novartis Pharma – CH)
- Dr. Gianluca Papeo (Nerviano Medical Sciences – I)
- Prof. Manlio Palumbo (Università di Padova – I)
New avenues in Carbohydrate Chemistry
- Prof. Sabine Flitsch (University of Manchester – UK)
- Prof. Hermen Overkleeft (University of Leiden- NL)
- Prof. Carlo Unverzagt (University of Bayreuth – D)
- Prof. Laura Cipolla (Università di Milano Bicocca – I)
Protein-protein interactions: Structures and druggability
- Prof. Thomas L. Blundell (University of Cambridge – UK)
- Prof. Maurizio Pellecchia (UCR School of Medicine – USA)
- Dr. Francesca Bernardini (Polyphor Ltd – CH)
Hot Topics
- Dr. Marie-Priscille BRUN (Sanofi – F)
- Prof. Stefano Salmaso (Università di Padova – I)
- Dr. Yves P. Auberson (Novartis – CH)
- Dr. Alleyn Plowright(AstraZeneca – S)